



The most undervalued CDMO stocks in India to watch
India's pharmaceutical reputation, however, was harder to contain.This wasn't an anomaly. It was a pattern.
For decades, India has worn the badge of the world's pharmacy with pride, and for good reason. Indian manufacturers supply nearly 20% of global generic medicines by volume.But affordability built on shaky manufacturing standards is a ticking clock.
So it was about time regulators stepped in, and they did so in January 2026.The Drugs Controller General of India mandated full enforcement of Schedule M norms that set baseline manufacturing standards covering factory design, hygiene, quality systems, staff training, and process validation.Within the pharma segment, the CDMO, or contract manufacturing, space is very interesting. It’s touted as the fastest-growing segment of the vast healthcare industry.Many pharma companies in India have stepped up in CDMO and are well placed to capture this opportunity.With that in mind, we look at some undervalued CDMO stocks investors should track.These stocks are filtered using Equitymaster’s stock screener: Best Pharma CDMO Stocks.Akums Drugs & Pharmaceuticals stands out as the largest CDMO in the Indian market, with roughly 30% share of outsourced manufacturing for domestic pharma companies.It caters to therapeutic areas such as cardio-diabetes, neurology, gynaecology, nephrology, anti-infectives, respiratory, analgesics, and multi-vitamins.Twenty-six of the top 30 Indian pharma firms are its clients.
Read on livemint.com